Viadur Approved for Treatment of Advanced Prostate
Cancer Testosterone suppression or hormonal therapy is
commonly used for the palliative treatment of patients with advanced prostate
cancer. Viadur (leuprolide acetate), approved by the FDA in March, is an
implant that suppresses testosterone production by delivering leuprolide for
up to one year.